Learn how two studies from Denmark expand upon earlier U.S. work that first linked the medication with the eye disease.

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Ozempic's meteoric rise has reshaped the landscape of healthcare, retail, and consumer behavior. Its initial popularity as a weight loss ...

While avoiding weight gain has long been considered a matter of personal willpower, the rise of "food noise" shows New Year's resolutions are never enough.

One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

GLP-1 inhibitor drugs might affect everything from food noise to Alzheimer's. Experts answer your top questions about their ...

Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down the risks of the trend.

Weight loss drugs like Ozempic and Wegovy have seemingly taken over this year, curbing users appetites by making them feel ...